DEMANE MICHAEL F 4
4 · NEVRO CORP · Filed May 30, 2023
Insider Transaction Report
Form 4
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-05-25+6,754→ 107,772 total
Holdings
- 18,266(indirect: See footnote)
Common Stock
- 82,541(indirect: See footnote)
Common Stock
- 91,225(indirect: See footnote)
Common Stock
- 164,344(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2023 or (ii) the next Annual Meeting following May 25, 2023, subject to the Reporting Person's continued service to the Issuer.
- [F2]Includes 6,754 RSUs.
- [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
- [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
- [F6]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.